Arkolith/Insider Trading/CLSD/Form 4/A

Thorp Clay

DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4/A · filed Dec 19, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$146K
Net Open-Market Flow
-$146K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 10, 2021Sell(S)33K$4.43$146K5.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-22-062044) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML